← Leaderboards
Vidu Garg
Research Inst Nationwide Children'S Hosp
$10,712,827
Attributed
$16,291,925
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,291,925 · 13
By mechanism
R01$12,879,814 · 7
T32$2,289,334 · 2
K08$540,000 · 1
R25$330,777 · 1
R21$231,000 · 1
R13$21,000 · 1
Top collaborators
- Peter J Mohler7 shared
- Peter White6 shared
- Joy Lincoln5 shared
- Brenda J Lilly4 shared
- Kim Lewis Mcbride4 shared
- Carl Backes3 shared
- Deena Chisolm2 shared
- Aaron J Trask2 shared
Most similar at Research Inst Nationwide Children'S Hosp
Same institution · by research overlap
- Peter White$1,725,496
- Mingtao Zhao$2,889,707
- Deena Chisolm$7,034,818
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularGeneticCause Of DeathCongenital AbnormalityMutationPathway InteractionsAffectGenetic Predisposition To DiseaseHeartGenesIn VitroCellsCongenital Heart DefectsIn VivoCongenital Heart DisorderBaseCardiacCell LineagePhenotypeMorbidity - Disease RateNotch ProteinChildhoodGene TargetingSignal Transduction
Grant awards (47)
Mechanisms and Therapeutics for Congenital Aortic Valve Disease$664,824
R01 · FY2025 · HL · contact PI
The Role of Notch Signaling in Type 2 Diabetic Coronary Microvascular Disease$608,406
R01 · FY2025 · HL
Integrative Research Training Program in Pediatric Cardiopulmonary Disease$349,536
T32 · FY2025 · HL · contact PI
Mechanisms and Therapeutics for Congenital Aortic Valve Disease$664,824
R01 · FY2024 · HL · contact PI
The Role of Notch Signaling in Type 2 Diabetic Coronary Microvascular Disease$596,237
R01 · FY2024 · HL
Integrative Research Training Program in Pediatric Cardiopulmonary Disease$369,366
T32 · FY2024 · HL · contact PI
Research Experiences in Childhood Heart, Lung, and Blood Science - REaCH LABS$165,628
R25 · FY2024 · HL
Integrative Research Training Program in Pediatric Cardiopulmonary Disease$339,234
T32 · FY2023 · HL · contact PI
Research Experiences in Childhood Heart, Lung, and Blood Science - REaCH LABS$165,149
R25 · FY2023 · HL
A Multi-omic approach towards improving candidate gene identification and variant prioritization in patients with congenital heart disease$115,500
R21 · FY2023 · HL · contact PI
Epigenetic Mechanisms Underlying Maternal Diabetes Associated Cardiac Malformations$380,000
R01 · FY2022 · HL · contact PI
A Multi-omic approach towards improving candidate gene identification and variant prioritization in patients with congenital heart disease$115,500
R21 · FY2022 · HL · contact PI
Epigenetic Mechanisms Underlying Maternal Diabetes Associated Cardiac Malformations$380,000
R01 · FY2021 · HL · contact PI
Epigenetic Mechanisms Underlying Maternal Diabetes Associated Cardiac Malformations$380,000
R01 · FY2020 · HL · contact PI
The Role of Notch in Calcific Aortic Valve Disease$641,682
R01 · FY2019 · HL
Epigenetic Mechanisms Underlying Maternal Diabetes Associated Cardiac Malformations$380,000
R01 · FY2019 · HL · contact PI
Training in Congenital and Acquired Heart Disease$28,281
T32 · FY2019 · HL · contact PI
The Role of Notch in Calcific Aortic Valve Disease$661,914
R01 · FY2018 · HL
Molecular Mechanisms of Aortic Valve Formation$426,841
R01 · FY2018 · HL · contact PI
Training in Congenital and Acquired Heart Disease$349,265
T32 · FY2018 · HL · contact PI
The Role of Notch in Calcific Aortic Valve Disease$652,108
R01 · FY2017 · HL
Molecular Mechanisms of Aortic Valve Formation$373,750
R01 · FY2017 · HL · contact PI
Training in Congenital and Acquired Heart Disease$333,406
T32 · FY2017 · HL · contact PI
Molecular Mechanisms of Aortic Valve Formation$68,850
R01 · FY2017 · HL · contact PI
Weinstein Cardiovascular Development Conference$21,000
R13 · FY2017 · HL
Training in Acquired and Congenital Heart Disease$10,392
T32 · FY2017 · HL · contact PI
Training in Congenital and Acquired Heart Disease$2,592
T32 · FY2017 · HL · contact PI
The Role of Notch in Calcific Aortic Valve Disease$677,141
R01 · FY2016 · HL
Molecular Mechanisms of Aortic Valve Formation$373,750
R01 · FY2016 · HL · contact PI
Training in Congenital and Acquired Heart Disease$200,848
T32 · FY2016 · HL · contact PI
Exome sequencing and functional studies in familial CHD$649,481
R01 · FY2015 · HL
Molecular Mechanisms of Aortic Valve Formation$373,750
R01 · FY2015 · HL · contact PI
Training in Congenital and Acquired Heart Disease$306,414
T32 · FY2015 · HL · contact PI
Exome sequencing and functional studies in familial CHD$664,040
R01 · FY2014 · HL
Exome sequencing and functional studies in familial CHD$669,080
R01 · FY2013 · HL
Exome sequencing and functional studies in familial CHD$695,636
R01 · FY2012 · HL
Genetic Regulation of Cardiac Septation$360,000
R01 · FY2011 · HL · contact PI
Genetic Regulation of Cardiac Septation$360,000
R01 · FY2010 · HL · contact PI
Genetic Regulation of Cardiac Septation$242,001
R01 · FY2009 · HL · contact PI
Genetic Regulation of Cardiac Septation$150,499
R01 · FY2009 · HL · contact PI
Genetic Regulation of Cardiac Septation$392,500
R01 · FY2008 · HL · contact PI
Genetic Regulation of Cardiac Septation$392,500
R01 · FY2007 · HL · contact PI
THE ROLE OF UFD1 AND CDC45 IN NEURAL CREST DEVELOPMENT$108,000
K08 · FY2004 · HD
THE ROLE OF UFD1 AND CDC45 IN NEURAL CREST DEVELOPMENT$108,000
K08 · FY2003 · HD
THE ROLE OF UFD1 AND CDC45 IN NEURAL CREST DEVELOPMENT$108,000
K08 · FY2002 · HD
THE ROLE OF UFD1 AND CDC45 IN NEURAL CREST DEVELOPMENT$108,000
K08 · FY2001 · HD
THE ROLE OF UFD1 AND CDC45 IN NEURAL CREST DEVELOPMENT$108,000
K08 · FY2000 · HD